Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.
Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis.
Cerebrotendinous xanthomatosis treatment includes chenodeoxycholic acid and HMG-CoA-reductase inhibitors.
Mosbach, A biochemical abnormality in cerebrotendinous xanthomatosis: impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain, J.
(5.) Cruysberg R., Cerebrotendinous xanthomatosis: juvenile cataract and chronic diarrhea before the onset of neurologic disease, Arch.
A neurological rarity not to bemissed: cerebrotendinous xanthomatosis. Pract Neurol 2011; 11 (5): 296-300.Gallus GN, Dotti MT, Federico A.